European Commission approves revolutionary prostate cancer drug co-developed by Czech scientist
The European Commission recently approved a new prostate cancer drug called Pluvicto, co-developed by a Czech researcher.
Source: english.radio.cz
Stay updated with breaking news from Lubor Urb. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The European Commission recently approved a new prostate cancer drug called Pluvicto, co-developed by a Czech researcher.